Literature DB >> 16864819

Peripheral neuropathy in Krabbe disease: electrodiagnostic findings.

Zaeem A Siddiqi1, Donald B Sanders, Janice M Massey.   

Abstract

BACKGROUND: Krabbe disease (KD) is associated with marked central and peripheral demyelination and nerve conduction studies (NCS) typically show a mixed sensorimotor demyelinating peripheral neuropathy (PN).
OBJECTIVES: To further characterize the PN in a large cohort of patients with KD and to assess the diagnostic sensitivity of NCS in this condition.
METHODS: The authors report the results of electrodiagnostic studies performed in 27 children with KD, ranging in age from 1 day to 8 years, whose diagnosis was confirmed by leukocyte lysosomal enzyme analysis.
RESULTS: Based on age-adjusted normative values, 25 of 27 patients had abnormal NCS (sensitivity > 90%) when at least one motor and one sensory nerve were tested in a lower and an upper extremity. Of the 24 patients with the early infantile form of the disease, 23 had abnormal NCS (sensitivity > 95%). Abnormal sural sensory responses (SNR) (82%), F-wave latencies (FWL) (85%), motor conduction velocities (CV) (82%), and distal motor latencies (DL) (76%) were the most sensitive indices. In the lower extremities the sensitivity of motor CV, FWL, and motor DL was 79%, 79%, and 57%, respectively, while in the upper limbs the corresponding sensitivities were 80%, 87%, and 73%. No conduction block was detected and there was uniform slowing of CV. SNR was unobtainable or abnormal in 82% of patients. The compound muscle action potential amplitudes were within normal limits in >70% of lower limb and >45% of upper limb responses. Marked NCS abnormalities were found in a 1-day-old and two 3-week-old neonates, the youngest patients reported to date. NCS were abnormal in 5/9 children with normal EEG or evoked potentials. The severity of the demyelination on NCS correlated well with the clinical severity of the disease.
CONCLUSIONS: Peripheral neuropathy occurs very early in Krabbe disease and affects the nerves uniformly. Nerve conduction studies may provide a highly sensitive tool to screen this patient population.

Entities:  

Mesh:

Year:  2006        PMID: 16864819     DOI: 10.1212/01.wnl.0000230153.34613.84

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).

Authors:  Allison M Bradbury; Jessica H Bagel; Xuntian Jiang; Gary P Swain; Maria L Prociuk; Caitlin A Fitzgerald; Patricia A O'Donnell; Kyle G Braund; Daniel S Ory; Charles H Vite
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Stem cell transplantation for adult-onset krabbe disease: report of a case.

Authors:  Madeleine E Sharp; Cornelia Laule; Stephen Nantel; Burkhard Mädler; Ritu B Aul; Samuel Yip; Sandra Sirrs
Journal:  JIMD Rep       Date:  2012-12-29

3.  Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.

Authors:  Gregory B Potter; Marta Santos; Muriel T Davisson; David H Rowitch; Dan L Marks; Ernesto R Bongarzone; Magdalena A Petryniak
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

4.  Cystic Changes and Optic Nerve Hypertrophy in Early Infantile Neuroregression.

Authors:  Indar Kumar Sharawat; Arushi Gahlot Saini; Sameer Vyas; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2019-05-16       Impact factor: 1.967

5.  Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy.

Authors:  Alessandra Ricca; Nicole Rufo; Silvia Ungari; Francesco Morena; Sabata Martino; Wilem Kulik; Valeria Alberizzi; Alessandra Bolino; Francesca Bianchi; Ubaldo Del Carro; Alessandra Biffi; Angela Gritti
Journal:  Hum Mol Genet       Date:  2015-03-05       Impact factor: 6.150

Review 6.  Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases.

Authors:  Marianna Mekhaeil; Kumlesh Kumar Dev; Melissa Jane Conroy
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

Review 7.  A neglected neurodegenerative disease: Adult-onset globoid cell leukodystrophy.

Authors:  Guode Wu; Zhenhua Li; Jing Li; Xin Li; Manxia Wang; Jing Zhang; Guangyao Liu; Pengfei Zhang
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

Review 8.  PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.

Authors:  Barbara W van Paassen; Anneke J van der Kooi; Karin Y van Spaendonck-Zwarts; Camiel Verhamme; Frank Baas; Marianne de Visser
Journal:  Orphanet J Rare Dis       Date:  2014-03-19       Impact factor: 4.123

9.  Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.

Authors:  Vasco Meneghini; Annalisa Lattanzi; Luigi Tiradani; Gabriele Bravo; Francesco Morena; Francesca Sanvito; Andrea Calabria; John Bringas; Jeanne M Fisher-Perkins; Jason P Dufour; Kate C Baker; Claudio Doglioni; Eugenio Montini; Bruce A Bunnell; Krystof Bankiewicz; Sabata Martino; Luigi Naldini; Angela Gritti
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.